Ameritas Investment Partners’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-10,547
Closed -$32.1K 3172
2024
Q4
$32.1K Hold
10,547
﹤0.01% 2425
2024
Q3
$54.7K Buy
10,547
+2,258
+27% +$11.7K ﹤0.01% 2140
2024
Q2
$21.3K Hold
8,289
﹤0.01% 2583
2024
Q1
$40.8K Hold
8,289
﹤0.01% 2262
2023
Q4
$72.9K Hold
8,289
﹤0.01% 1937
2023
Q3
$95.1K Buy
8,289
+1,400
+20% +$16.1K ﹤0.01% 1690
2023
Q2
$174K Buy
6,889
+428
+7% +$10.8K 0.01% 1227
2023
Q1
$208K Hold
6,461
0.01% 1073
2022
Q4
$217K Buy
6,461
+1,099
+20% +$36.8K 0.01% 1091
2022
Q3
$144K Hold
5,362
0.01% 1253
2022
Q2
$74K Hold
5,362
﹤0.01% 1715
2022
Q1
$105K Hold
5,362
﹤0.01% 1625
2021
Q4
$88K Hold
5,362
﹤0.01% 1761
2021
Q3
$149K Hold
5,362
0.01% 1432
2021
Q2
$159K Hold
5,362
0.01% 1421
2021
Q1
$150K Hold
5,362
0.01% 1401
2020
Q4
$152K Hold
5,362
0.01% 1306
2020
Q3
$135K Buy
5,362
+345
+7% +$8.69K 0.01% 1256
2020
Q2
$123K Buy
5,017
+978
+24% +$24K 0.01% 1284
2020
Q1
$60K Buy
4,039
+268
+7% +$3.98K ﹤0.01% 1564
2019
Q4
$61K Hold
3,771
﹤0.01% 1806
2019
Q3
$49K Hold
3,771
﹤0.01% 1889
2019
Q2
$49K Buy
3,771
+939
+33% +$12.2K ﹤0.01% 1927
2019
Q1
$45K Hold
2,832
﹤0.01% 1948
2018
Q4
$57K Hold
2,832
﹤0.01% 1732
2018
Q3
$70K Hold
2,832
﹤0.01% 1786
2018
Q2
$78K Buy
2,832
+560
+25% +$15.4K ﹤0.01% 1702
2018
Q1
$70K Buy
2,272
+303
+15% +$9.34K ﹤0.01% 1723
2017
Q4
$70K Hold
1,969
﹤0.01% 1726
2017
Q3
$48K Hold
1,969
﹤0.01% 1924
2017
Q2
$52K Buy
1,969
+542
+38% +$14.3K ﹤0.01% 1879
2017
Q1
$30K Buy
+1,427
New +$30K ﹤0.01% 2169